Researchers develop mathematical measures to better personalize therapy for prostate cancer. Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from routine prostate-specific antigen (PSA) blood tests.
- Ponto de atenção: researchers.
- Ponto de atenção: develop.
- Ponto de atenção: mathematical.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
